Inquis Medical, Inc.

Inquis Medical, Inc. is a clinical-stage medical device company specializing in interventional solutions for venous thromboembolic (VTE) diseases, including pulmonary embolism (PE) and deep vein thrombosis (DVT). The company develops the AVENTUS Precision Thrombectomy System, a catheter-based device engineered for precise clot removal while minimizing blood loss during endovascular interventions. The AVENTUS system incorporates proprietary TrueClot™ Sensing technology for real-time tissue differentiation, directional aspiration for targeted clot retrieval, and integrated autologous blood return to optimize procedural efficiency and patient outcomes. The device received FDA 510(k) clearance for PE treatment in June 2025 and has completed successful clinical trials. Founded in 2019, Inquis Medical is based in Menlo Park, California, with a mission to deliver "care without compromise" in interventional cardiology and peripheral vascular medicine.